Novel Interaction between Proliferating Cell Nuclear Antigen and HLA I on the Surface of Tumor Cells Inhibits NK Cell Function through NKp44

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Horton, Nathan C ^a   Mathew, Stephen O ^a   Mathew, Porunelloor A ^a  

^a UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; HLA ANTIGEN CLASS 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2;

ARTICLE; CELL FUNCTION; CELL MEDIATED CYTOTOXICITY; CELL SURFACE; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MOLECULAR INTERACTION; NATURAL KILLER CELL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TUMOR CELL;

CELL LINE, TUMOR; CELL MEMBRANE; CHROMIUM RADIOISOTOPES; DNA PRIMERS; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOPRECIPITATION; KILLER CELLS, NATURAL; MICROSCOPY, CONFOCAL; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NEOPLASMS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 84875119465     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059552     Document Type: Article

References (37)

1. Lanier LL, (2008) Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 9: 495-502.
2. Colonna M, Jonjic S, Watzl C, (2011) Natural killer cells: fighting viruses and much more. Nat Immunol 12: 107-110.
3. Lanier LL, Phillips JH, (1995) NK cell recognition of major histocompatibility complex class I molecules. Semin Immunol 7: 75-82.
4. Moretta L, Moretta A, (2004) Unravelling natural killer cell function: triggering and inhibitory human NK receptors. Embo J 23: 255-259.
5. Moretta A, Bottino C, Vitale M, Pende D, Cantoni C, et al. (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu Rev Immunol 19: 197-223.
6. Bottino C, Castriconi R, Moretta L, Moretta A, (2005) Cellular ligands of activating NK receptors. Trends Immunol 26: 221-226.
7. Cantoni C, Bottino C, Vitale M, Pessino A, Augugliaro R, et al. (1999) NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med 189: 787-796.
8. Rosental B, Brusilovsky M, Hadad U, Oz D, Appel MY, et al. (2011) Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44. J Immunol 187: 5693-5702.
9. Campbell KS, Yusa S, Kikuchi-Maki A, Catina TL, (2004) NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence. J Immunol 172: 899-906.
10. Sivori S, Parolini S, Marcenaro E, Castriconi R, Pende D, et al. (2000) Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines. J Neuroimmunol 107: 220-225.
11. Sivori S, Parolini S, Marcenaro E, Millo R, Bottino C, et al. (2000) Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines. Hum Immunol 61: 1055-1058.
12. Vieillard V, Strominger JL, Debre P, (2005) NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. Proc Natl Acad Sci U S A 102: 10981-10986.
13. Stoimenov I, Helleday T, (2009) PCNA on the crossroad of cancer. Biochem Soc Trans 37: 605-613.
14. El Costa H, Tabiasco J, Berrebi A, Parant O, Aguerre-Girr M, et al. (2009) Effector functions of human decidual NK cells in healthy early pregnancy are dependent on the specific engagement of natural cytotoxicity receptors. J Reprod Immunol 82: 142-147.
15. Naryzhny SN, Lee H, (2007) Characterization of proliferating cell nuclear antigen (PCNA) isoforms in normal and cancer cells: there is no cancer-associated form of PCNA. FEBS Lett 581: 4917-4920.
16. Naryzhny SN, Lee H, (2010) Proliferating cell nuclear antigen in the cytoplasm interacts with components of glycolysis and cancer. FEBS Lett 584: 4292-4298.
17. Betser-Cohen G, Mizrahi S, Elboim M, Alsheich-Bartok O, Mandelboim O, (2010) The association of MHC class I proteins with the 2B4 receptor inhibits self-killing of human NK cells. J Immunol 184: 2761-2768.
18. Specht A, DeGottardi MQ, Schindler M, Hahn B, Evans DT, et al. (2008) Selective downmodulation of HLA-A and-B by Nef alleles from different groups of primate lentiviruses. Virology 373: 229-237.
19. Fausther-Bovendo H, Sol-Foulon N, Candotti D, Agut H, Schwartz O, et al. (2009) HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells. Aids 23: 1077-1087.
20. Pogge von Strandmann E, Simhadri VR, von Tresckow B, Sasse S, Reiners KS, et al. (2007) Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells. Immunity 27: 965-974.
21. Simhadri VR, Reiners KS, Hansen HP, Topolar D, Simhadri VL, et al. (2008) Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer function. PLoS One 3: e3377.
22. Parolini I, Federici C, Raggi C, Lugini L, Palleschi S, et al. (2009) Microenvironmental pH is a key factor for exosome traffic in tumor cells. J Biol Chem 284: 34211-34222.
23. Medici D, Kalluri R, (2012) Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype. Semin Cancer Biol 22: 379-384.
24. Patrawala L, Calhoun-Davis T, Schneider-Broussard R, Tang DG, (2007) Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells. Cancer Res 67: 6796-6805.
25. Soule HD, Vazguez J, Long A, Albert S, Brennan M, (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51: 1409-1416.
26. Tam YK, Maki G, Miyagawa B, Hennemann B, Tonn T, et al. (1999) Characterization of genetically altered, interleukin 2-independent natural killer cell lines suitable for adoptive cellular immunotherapy. Hum Gene Ther 10: 1359-1373.
27. Liu Y, Chen Z, Niu N, Chang Q, Deng R, et al. (2012) IgG gene expression and its possible significance in prostate cancers. Prostate 72: 690-701.
28. Qin HR, Kim HJ, Kim JY, Hurt EM, Klarmann GJ, et al. (2008) Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation. Cancer Res 68: 7736-7741.
29. Morris GF, Bischoff JR, Mathews MB, (1996) Transcriptional activation of the human proliferating-cell nuclear antigen promoter by p53. Proc Natl Acad Sci U S A 93: 895-899.
30. Shivakumar CV, Brown DR, Deb S, Deb SP, (1995) Wild-type human p53 transactivates the human proliferating cell nuclear antigen promoter. Mol Cell Biol 15: 6785-6793.
31. Sasaki T, Gan EC, Wakeham A, Kornbluth S, Mak TW, et al. (2007) HLA-B-associated transcript 3 (Bat3)/Scythe is essential for p300-mediated acetylation of p53. Genes Dev 21: 848-861.
32. Delahaye NF, Rusakiewicz S, Martins I, Menard C, Roux S, et al. (2011) Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. Nat Med 17: 700-707.
33. Hecht ML, Rosental B, Horlacher T, Hershkovitz O, De Paz JL, et al. (2009) Natural cytotoxicity receptors NKp30, NKp44 and NKp46 bind to different heparan sulfate/heparin sequences. J Proteome Res 8: 712-720.
34. Hershkovitz O, Jivov S, Bloushtain N, Zilka A, Landau G, et al. (2007) Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44. Biochemistry 46: 7426-7436.
35. Srikrishna G, Freeze HH, (2009) Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 11: 615-628.
36. Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA, et al. (2007) The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunol Rev 220: 60-81.
37. Nickel W, Seedorf M, (2008) Unconventional mechanisms of protein transport to the cell surface of eukaryotic cells. Annu Rev Cell Dev Biol 24: 287-308.